Loading...
XNASNEOG
Market cap2.69bUSD
Dec 27, Last price  
12.43USD
1D
0.00%
1Q
-25.17%
Jan 2017
-74.89%
Name

Neogen Corp

Chart & Performance

D1W1MN
XNAS:NEOG chart
P/E
P/S
2.91
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
15.60%
Rev. gr., 5y
17.41%
Revenues
924m
+12.37%
62,756,00072,433,00086,138,000102,418,000118,721,000140,509,000172,683,000184,046,000207,528,000247,405,000283,074,000321,275,000361,594,000402,252,000414,186,000418,170,000468,459,000527,159,000822,447,000924,222,000
Net income
-9m
L-58.81%
5,916,0007,941,0009,125,00012,098,00013,874,00017,521,00022,839,00022,513,00027,190,00028,158,00033,526,00036,564,00043,793,00063,145,00060,176,00059,475,00060,882,00048,307,000-22,870,000-9,421,000
CFO
35m
-14.05%
6,722,00012,313,00010,158,0007,873,00010,985,00027,988,00028,843,00022,277,00026,561,00021,668,00043,792,00035,331,00060,274,00069,131,00063,842,00085,878,00081,089,00068,038,00041,028,00035,264,000
Earnings
Jan 07, 2025

Profile

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
IPO date
Aug 23, 1989
Employees
2,640
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑052023‑052022‑052021‑052020‑052019‑052018‑052017‑052016‑052015‑05
Income
Revenues
924,222
12.37%
822,447
56.01%
527,159
12.53%
Cost of revenue
865,559
784,932
468,541
Unusual Expense (Income)
NOPBT
58,663
37,515
58,618
NOPBT Margin
6.35%
4.56%
11.12%
Operating Taxes
(4,884)
828
11,900
Tax Rate
2.21%
20.30%
NOPAT
63,547
36,687
46,718
Net income
(9,421)
-58.81%
(22,870)
-147.34%
48,307
-20.65%
Dividends
Dividend yield
Proceeds from repurchase of equity
2,456
7,933
BB yield
-0.09%
-0.28%
Debt
Debt current
7,548
1,440
Long-term debt
901,138
903,063
1,790
Deferred revenue
(353,427)
17,011
Other long-term liabilities
351,677
27,065
(8,099)
Net debt
737,521
692,101
(368,739)
Cash flow
Cash from operating activities
35,264
41,028
68,038
CAPEX
(111,421)
(65,757)
(24,429)
Cash from investing activities
(29,309)
201,039
(97,229)
Cash from financing activities
1,918
(118,081)
6,813
FCF
(109,723)
(83,976)
25,294
Balance
Cash
170,936
245,569
381,051
Long term investments
229
(34,607)
(9,082)
Excess cash
124,954
169,840
345,611
Stockholders' equity
560,257
566,389
577,390
Invested Capital
4,277,104
3,885,693
551,777
ROIC
1.56%
1.65%
8.95%
ROCE
1.33%
0.85%
6.41%
EV
Common stock shares outstanding
216,482
188,881
108,020
Price
13.15
-24.81%
17.49
-33.90%
26.46
-42.67%
Market cap
2,846,737
-13.83%
3,303,529
15.58%
2,858,209
-42.18%
EV
3,584,258
3,995,630
2,489,470
EBITDA
179,890
125,892
82,312
EV/EBITDA
19.92
31.74
30.24
Interest
73,394
55,961
1,267
Interest/NOPBT
125.11%
149.17%
2.16%